CAM
DXCM icon

Cresset Asset Management’s DexCom DXCM Stock Holding History

Cresset Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Buy
6,133
+19
+0.3% +$1.27K ﹤0.01% 1246
2026
Q1 		$384K Buy
6,114
+71
+1% +$4.94K ﹤0.01% 1175
2025
Q4 		$401K Sell
6,043
-148
-2% -$9.57K ﹤0.01% 1171
2025
Q3 		$417K Buy
6,191
+476
+8% +$37.7K ﹤0.01% 1105
2025
Q2 		$499K Sell
5,715
-12,335
-68% -$967K ﹤0.01% 940
2025
Q1 		$1.23M Sell
18,050
-3,404
-16% -$278K 0.01% 697
2024
Q4 		$1.67M Sell
21,454
-23,375
-52% -$1.73M 0.01% 608
2024
Q3 		$3.01M Sell
44,829
-8,628
-16% -$709K 0.01% 625
2024
Q2 		$6.06M Buy
53,457
+1,355
+3% +$171K 0.03% 387
2024
Q1 		$7.23M Buy
52,102
+13,876
+36% +$1.74M 0.03% 310
2023
Q4 		$4.74M Buy
38,226
+194
+0.5% +$19.8K 0.03% 351
2023
Q3 		$3.55M Sell
38,032
-643
-2% -$72.5K 0.01% 404
2023
Q2 		$4.97M Buy
38,675
+32,002
+480% +$3.87M 0.01% 415
2023
Q1 		$775K Sell
6,673
-1,793
-21% -$201K 0.02% 389
2022
Q4 		$959K Sell
8,466
-103
-1% -$11.3K 0.01% 308
2022
Q3 		$690K Sell
8,569
-270
-3% -$22.9K 0.01% 430
2022
Q2 		$659K Sell
8,839
-4,933
-36% -$450K 0.01% 477
2022
Q1 		$1.76M Buy
13,772
+2,368
+21% +$259K 0.02% 269
2021
Q4 		$1.53M Buy
11,404
+3,056
+37% +$439K 0.01% 343
2021
Q3 		$1.14M Sell
8,348
-6,492
-44% -$819K 0.02% 354
2021
Q2 		$1.58M Buy
14,840
+12,096
+441% +$1.16M 0.02% 247
2021
Q1 		$247K Buy
2,744
+468
+21% +$43.9K ﹤0.01% 770
2020
Q4 		$210K Sell
2,276
-364
-14% -$32.5K ﹤0.01% 700
2020
Q3 		$272K Buy
2,640
+288
+12% +$30.1K 0.01% 543
2020
Q2 		$238K Buy
+2,352
New +$210K 0.01% 549
2019
Q2 		– Sell
-7,008
Closed -$209K – 796
2019
Q1 		$209K Buy
7,008
+6,556
+1,450% +$230K 0.01% 362
2018
Q4 		$14K Buy
+452
New +$14.3K ﹤0.01% 783

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cresset Asset Management's DXCM Position: Q2 2026 in Review

Cresset Asset Management increased its DexCom (DXCM) stake by 0.31% in Q2 2026, buying an estimated $1.27K and bringing the position to 6,133 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #1246.

Cresset Asset Management first reported a position in DXCM in Q4 2018 and has held it in 27 quarters since. The position peaked at $7.23M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cresset Asset Management held 6,133 shares of DexCom worth $413K as of Q2 2026.
  • Cresset Asset Management bought 19 DexCom shares in Q2 2026, an estimated $1.27K.
  • DexCom made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1246 holding.
  • Cresset Asset Management first reported a position in DexCom in Q4 2018 and has held it in 27 quarters since.
  • Cresset Asset Management's DexCom position peaked at $7.23M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.